Clinical trials for cannabidiol
The European Union Clinical Trials Register allows you to search for protocol and results information on:
The EU Clinical Trials Register currently displays 39365 clinical trials with a EudraCT protocol, of which 6450 are clinical trials conducted with subjects less than 18 years old.
The register also displays information on 18700 older paediatric trials (in scope of Article 45 of the Paediatric Regulation (EC) No 1901/2006).
- Trials with a EudraCT protocol (30)
- Paediatric studies in scope of Art45 of the Paediatric Regulation (0)
Subscribe to this Search
To subscribe to the RSS feed for this search click here . This will provide an RSS feed for clinical trials matching your search that have been added or updated in the last 7 days.
|Number of Trials to download:|
|Trials shown on current page
Selected Trials only –>
Full Trial Details –>
|Note, where multi-state trials are shown in search results, selecting “Full Trial details” will download full information for each of the member states/countries involved in the trial.|
Query did not match any studies.
Clinical trials for cannabidiol The European Union Clinical Trials Register allows you to search for protocol and results information on: interventional clinical trials that are conducted
A Guide To Cannabidiol (CBD) Clinical Trials
HomeClinical Trials A Guide To Cannabidiol (CBD) Clinical Trials
- Autoimmune Hepatitis
- Hepatitis C
- Multiple Sclerosis
- Breast Cancer
- Prostate Cancer
What is Cannabidiol (CBD)?
BD is the second most common active compound within the marijuana plant. It can be derived in relatively large quantities from hemp to be used for medical treatment. CBD has many potential applications for sufferers of chronic disease.
CBD has rapidly become a popular area of medical study for several reasons. First, it does not produce a high in patients who use it. Second, it does not appear to cause any symptoms of chemical dependency. A low potential for abuse or addiction makes it highly promising.
Match to Cannabidiol Clinical Trials
Access to cutting-edge treatments Latest clinical trials Find trials in your area
What Conditions Can CBD Treat or Cure?
CBD has a very long history as a treatment for those suffering from intense chronic pain. In particular, it is valuable for patients who cannot benefit from traditional medications as a result of damaged organs or a compromised immune system.
Doctors have been prescribing CBD for patients with advanced cancer or AIDS for many years. CBD can be helpful in reducing pain related to anti-cancer treatments such as chemotherapy. It may also temporarily improve or restore patients’ appetite.
More recently, CBD has been shown to have powerful effects on some patients suffering from seizure disorders. CBD-based treatments have been accepted as highly safe and effective for some younger patients whose epilepsy is resistant to conventional treatment.
The positive effects of CBD on individuals with other conditions is also being studied. These studies include psoriasis, multiple sclerosis, Parkinson’s disease, and as a potential treatment to preventing cancer cell growth.
What Research Currently Exists Around CBD?
Because CBD has only recently entered the medical mainstream, there are still many unanswered questions to be explored. Early research focused on the role of cannabinoid receptors in the brain in perceiving and processing CBD, as well as its effect on the brain’s production of dopamine.
Over the last few years, doctors have launched small-scale CBD studies and CBD clinical trials to find other potential uses for the compound. CBD is gaining notoriety as a potential treatment for a variety of mood disorders, especially generalized anxiety. It may even help PTSD sufferers.
Naturally, there is still much to learn about CBD. No long-term (“longitudinal”) study has shown the effects of CBD on brain structure or quality of life. It will be some time before a large enough patient community exists for a multi-decade CBD clinical study to be completed.
Why Are Further CBD Clinical Trials Important?
CBD is a substance humans have been in contact with for centuries. However, we know relatively little about its potential applications in modern medicine. Much of the data that exists is for older patients and those who have suffered chronic conditions for many years.
Promising CBD medical discoveries point to the possibility that it might be useful for a wide range of conditions throughout life. The better doctors come to understand how CBD affects the perception of pain, the easier it will be to prescribe effective and safe doses.
CBD can be refined to be very mild or very potent. It can also be introduced into the body in a whole spectrum of ways. Further CBD clinical trials are needed to gain a full understanding of the best way for patients to use CBD based on their health situation.
Current CBD Clinical Trials
The following CBD trials are the most up to date known to ClinicalTrials.gov. If you would like to showcase a clinical study on this page, contact our team.
ClinicalTrials.gov: Recruiting Studies | Cannabidiol | Last update posted in the last 300 days Studies found on ClinicalTrials.gov by a search of: Recruiting Studies | Cannabidiol | Last update posted in the last 300 days
Condition: COVID-19Intervention: Drug: CannabidiolSponsor: Rabin Medical CenterRecruiting
Conditions: Panic Attacks; Panic Disorder; AgoraphobiaInterventions: Behavioral: Memory Reactivation; Dietary Supplement: Cannabidiol (CBD) Oil; Dietary Supplement: Placebo OilSponsors: University of Texas at Austin; Way West Hemp Inc.Recruiting
Condition: Electrical Status Epilepticus of Slow-Wave SleepInterventions: Drug: Epidiolex 100 mg/mL Oral Solution; Other: PlaceboSponsors: Northwell Health; Greenwich BiosciencesRecruiting
Condition: Diabetic Peripheral Neuropathic PainInterventions: Drug: CBD; Drug: PlaceboSponsor: Pure GreenRecruiting
Condition: Pain, PostoperativeInterventions: Other: CBD Oral Disintegrating Tablet (ODT); Other: Placebo ODTSponsor: NYU Langone HealthRecruiting
Conditions: CBD; Hand OsteoarthritisInterventions: Drug: CBD; Drug: Shea ButterSponsor: University of VirginiaRecruiting
Conditions: Dravet Syndrome; Lennox Gastaut SyndromeIntervention: Drug: CannabidiolSponsor: Yonsei UniversityRecruiting
Conditions: Osteo Arthritis Knee; Pain, JointInterventions: Drug: Cannabidiol Oral Product; Drug: PlaceboSponsor: Medical University of ViennaRecruiting
Condition: Drug InteractionInterventions: Drug: di-Methylphenidate plus Cannabidiol; Drug: di-Methylphenidate plus Cannabidiol Placebo solutionSponsors: University of Florida; State of Florida Consortium for Medical Marijuana Clinical Outcomes ResearchRecruiting
Conditions: Driving Performance; Cognitive Impairment; Sedation Complication; MoodInterventions: Drug: 300 mg Cannabidiol (CBD) oil; Drug: PlaceboSponsor: West Virginia UniversityRecruiting
Conditions: Lean Body Mass; Cannabis; Cancer; Nausea; Cachexia; Emesis; Appetitive BehaviorIntervention: Drug: CannabidiolSponsors: University of Copenhagen; Zealand University HospitalRecruiting
Condition: Chemotherapy-induced Peripheral NeuropathyIntervention: Drug: Cannabidiol 100 MG/MLSponsors: Zealand University Hospital; University of CopenhagenRecruiting
A Guide To Cannabidiol (CBD) Clinical Trials HomeClinical Trials A Guide To Cannabidiol (CBD) Clinical Trials Asthma Autoimmune Hepatitis CBD COPD Depression